Brown Brothers Harriman & Co’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-3,000
Closed -$13K 760
2017
Q1
$13K Hold
3,000
﹤0.01% 630
2016
Q4
$15K Hold
3,000
﹤0.01% 656
2016
Q3
$19K Hold
3,000
﹤0.01% 551
2016
Q2
$19K Hold
3,000
﹤0.01% 560
2016
Q1
$17K Hold
3,000
﹤0.01% 531
2015
Q4
$19K Hold
3,000
﹤0.01% 571
2015
Q3
$16K Hold
3,000
﹤0.01% 637
2015
Q2
$21K Hold
3,000
﹤0.01% 602
2015
Q1
$21K Hold
3,000
﹤0.01% 609
2014
Q4
$25K Hold
3,000
﹤0.01% 607
2014
Q3
$26K Hold
3,000
﹤0.01% 598
2014
Q2
$27K Hold
3,000
﹤0.01% 579
2014
Q1
$32K Hold
3,000
﹤0.01% 554
2013
Q4
$27K Hold
3,000
﹤0.01% 520
2013
Q3
$31K Hold
3,000
﹤0.01% 521
2013
Q2
$16K Buy
+3,000
New +$16.9K ﹤0.01% 635

Other funds holding CGEN

Brown Brothers Harriman & Co's CGEN Position: Q2 2017 in Review

Brown Brothers Harriman & Co sold out of Compugen (CGEN) in Q2 2017, closing a stake of 3,000 shares — an estimated $13K sold.

Brown Brothers Harriman & Co first reported a position in CGEN in Q2 2013 and held it in 16 quarters. The position peaked at $32K in Q1 2014. 37 funds tracked by Wall St. Rank hold CGEN as of Q2 2017.

  • Brown Brothers Harriman & Co reported no remaining Compugen position as of Q2 2017 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 3,000 Compugen shares in Q2 2017, an estimated $13K.
  • Brown Brothers Harriman & Co first reported a position in Compugen in Q2 2013 and held it in 16 quarters.
  • Brown Brothers Harriman & Co's Compugen position peaked at $32K in Q1 2014.
  • 37 funds tracked by Wall St. Rank held Compugen as of Q2 2017.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2017, filed 14 Aug 2017.